{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:35:47Z","timestamp":1789598147944,"version":"build-2803163510"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"CEP","award":["CEP"],"award-info":[{"award-number":["CEP"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Benzodiazepines are commonly used to treat anxiety and\/or insomnia but are associated with substantial safety risks. Changes to prescribing patterns in primary care may be facilitated through tailored quality improvement strategies. Academic detailing (AD) may be an effective method of promoting safe benzodiazepine prescribing. The objective of this study was to evaluate the effectiveness of AD on benzodiazepine prescribing among family physicians.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and findings<\/jats:title>\n<jats:p>We used an interrupted time series matched cohort design using population-based administrative claims databases. Participants were family physicians practicing in Ontario, Canada. The intervention was a voluntary AD service which involves brief service-oriented educational outreach visits by a trained pharmacist. The focus was on key messages for safer benzodiazepine prescribing in primary care with an emphasis on judicious prescribing to older adults aged 65 and older. Physicians in the intervention group were those who received at least one AD visit on benzodiazepine use between June 2019 and February 2020. Physicians in the control group were included if they did not receive an AD visit during the study period. Intervention physicians were matched to control physicians 1:4, on a variety of characteristics. Physicians were excluded if they had inactive billing or billing of less than 100 unique patient visits in the calendar year prior to the index date. The primary outcome was mean total benzodiazepine prescriptions at the level of the physician. Secondary outcomes were rate (per 100) of patients with long-term prescriptions, high-risk prescriptions, newly started prescriptions, and benzodiazepine-related patient harms. Data were analyzed using a repeated measures pre-post comparison with an intention-to-treat. Analyses were then stratified to focus on effects within higher-prescribing physicians.<\/jats:p>\n<jats:p>There were 1337 physicians were included in the study; 237 who received AD and 1064 who did not. There was no significant change in benzodiazepine prescribing when considering all physicians in the intervention and matched control groups. Although not significant, a greater reduction in total benzodiazepine prescriptions was observed amongst the highest-volume prescribing physicians who received the intervention (% change in slope = -0.53, 95%CI = -2.34 to 1.30, p &gt; .05).<\/jats:p>\n<jats:p>The main limitation of our study was the voluntary nature of the AD intervention, which may have introduced a self-selection bias of physicians most open to changing their prescribing.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This study suggests that future AD interventions should focus on physicians with the greatest room for improvement to their prescribing.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0289147","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T17:35:40Z","timestamp":1690479340000},"page":"e0289147","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effects of an academic detailing service on benzodiazepine prescribing patterns in primary care"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2583-9788","authenticated-orcid":true,"given":"Meagan","family":"Lacroix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Abdelmalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5437-6658","authenticated-orcid":true,"given":"Karl","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Salach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Bevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2500-2435","authenticated-orcid":true,"given":"Noah M.","family":"Ivers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1911-6129","authenticated-orcid":true,"given":"Mina","family":"Tadrous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"issue":"9","key":"pone.0289147.ref001","doi-asserted-by":"crossref","first-page":"e1003804","DOI":"10.1371\/journal.pmed.1003804","article-title":"Relative risks of adverse events among older adults receiving opioids versus NSAIDs after hospital discharge: A nationwide cohort study.","volume":"18","author":"SJ Herzig","year":"2021","journal-title":"PLOS Medicine"},{"key":"pone.0289147.ref002","unstructured":"Clinical Toolkit\u2014Benzodiazepines: Use and Taper: College of Physicians and Surgeons of Alberta. 2017 [cited 20 February 2023]. Available from: https:\/\/www.albertapt.com\/df_media\/W1siZiIsIjIwMjEvMDIvMDEvMTkvMzQvMDgvNzYwYjkzZGQtYmQxYS00Y2NmLWEwNDgtZGZlZmUxMWEzYzc4L0JlbnpvZGlhemVwaW5lcyBVc2UgYW5kIFRhcGVyLnBkZiJdXQ\/Benzodiazepines%20Use%20and%20Taper.pdf?sha=08cd532ef2a84d08."},{"key":"pone.0289147.ref003","unstructured":"Updates to safety labelling for benzodiazepines and benzodiazepine-like drugs: Health Canada. 2020 [cited 31 October 2022]. Available from: https:\/\/recalls-rappels.canada.ca\/en\/alert-recall\/updates-safety-labelling-benzodiazepines-and-benzodiazepine-drugs."},{"key":"pone.0289147.ref004","unstructured":"Prescribing guidelines for benzodiazepines in adults: National Health Service Clinical Commissioning Group; 2007 [updated March 2017; cited 1 November 2022]. Available from: https:\/\/www.dudleyformulary.nhs.uk\/download\/485\/benzodiazepines-in-adults-prescribing-guidelines."},{"key":"pone.0289147.ref005","first-page":"1","article-title":"CDC Guideline for Prescribing Opioids for Chronic Pain MMWR Recomm Rep.","volume":"65","author":"D Dowell","year":"2016"},{"key":"pone.0289147.ref006","unstructured":"Characterizing Prescription Benzodiazepine Use Among Community-Dwelling Residents of Ontario, Canada: Ontario Drug Policy Research Network. 2021 [updated April; cited 31 October 2022]. Available from: https:\/\/odprn.ca\/wp-content\/uploads\/2021\/04\/Trends-and-Patterns-in-the-Use-of-Benzodiazepines-in-Ontario.pdf."},{"issue":"1","key":"pone.0289147.ref007","doi-asserted-by":"crossref","first-page":"e187399","DOI":"10.1001\/jamanetworkopen.2018.7399","article-title":"Patterns in Outpatient Benzodiazepine Prescribing in the United States","volume":"2","author":"SD Agarwal","year":"2019","journal-title":"JAMA Network Open"},{"issue":"720","key":"pone.0289147.ref008","doi-asserted-by":"crossref","first-page":"e511","DOI":"10.3399\/BJGP.2021.0561","article-title":"Rise in prescribing for anxiety in UK primary care between 2003 and 2018: a population-based cohort study using Clinical Practice Research Datalink.","volume":"72","author":"C Archer","year":"2022","journal-title":"Br J Gen Pract"},{"issue":"4","key":"pone.0289147.ref009","doi-asserted-by":"crossref","first-page":"511","DOI":"10.18433\/J3KK6C","article-title":"Effectiveness of academic detailing to optimize medication prescribing behaviour of family physicians","volume":"16","author":"HK Chhina","year":"2013","journal-title":"J Pharm Pharm Sci"},{"issue":"4","key":"pone.0289147.ref010","first-page":"Cd000409","article-title":"Educational outreach visits: effects on professional practice and health care outcomes.","volume":"2007","author":"MA O\u2019Brien","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"pone.0289147.ref011","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jama.1990.03440040088034","article-title":"Principles of educational outreach (\u2019academic detailing\u2019) to improve clinical decision making","volume":"263","author":"SB Soumerai","year":"1990","journal-title":"Jama"},{"key":"pone.0289147.ref012","unstructured":"ICES data Institute for Clinical Evaluative Sciences. 2023 [cited 29 May 2023]. Available from: https:\/\/www.ices.on.ca\/Data-and-Privacy\/ICES-data."},{"key":"pone.0289147.ref013","unstructured":"Working with ICES data Institute for Clinical Evaluative Sciences. 2023 [cited 29 May 2023]. Available from: https:\/\/www.ices.on.ca\/Data-and-Privacy\/ICES-data\/Working-with-ICES-Data."},{"key":"pone.0289147.ref014","unstructured":"Centre for Effective Practice. 2023 [cited 15 May 2023]. Available from: https:\/\/cep.health\/."},{"issue":"12","key":"pone.0289147.ref015","doi-asserted-by":"crossref","first-page":"e0167479","DOI":"10.1371\/journal.pone.0167479","article-title":"High-Dose Opioid Prescribing and Opioid-Related Hospitalization: A Population-Based Study.","volume":"11","author":"L Spooner","year":"2016","journal-title":"PLOS ONE"},{"issue":"3","key":"pone.0289147.ref016","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/pds.5180","article-title":"Initial opioid prescription patterns and the risk of ongoing use and adverse outcomes.","volume":"30","author":"T Gomes","year":"2021","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"pone.0289147.ref017","unstructured":"Opioid dispensing in Ontario: 2018 snapshot: Ontario College of Pharmacists; 2019 [cited 1 November 2022]. Available from: https:\/\/www.ocpinfo.com\/wp-content\/uploads\/2019\/11\/opioid-dispensing-in-ontario-2018-snapshot.pdf."},{"key":"pone.0289147.ref018","volume-title":"Benzodiazepines for the Treatment of Adults with Mental Health Conditions or Sleep Disorders: Guidelines","author":"Y Li","year":"2019"},{"issue":"1","key":"pone.0289147.ref019","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5770\/cgj.23.419","article-title":"Canadian Guidelines on Benzodiazepine Receptor Agonist Use Disorder Among Older Adults Title.","volume":"23","author":"DK Conn","year":"2020","journal-title":"Can Geriatr J"},{"key":"pone.0289147.ref020","unstructured":"The Narcotics Safety and Awareness Act, 2010: Ontario Ministry of Health and Long Term Care; 2010 [updated 12 December 2018; cited 29 May 2023]. Available from: https:\/\/www.health.gov.on.ca\/en\/public\/programs\/drugs\/ons\/ons_legislation.aspx."},{"issue":"3","key":"pone.0289147.ref021","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/2045125317743651","article-title":"Benzodiazepine prescription in Ontario residents aged 65 and over: a population-based study from 1998 to 2013","volume":"8","author":"SJC Davies","year":"2018","journal-title":"Therapeutic advances in psychopharmacology"},{"key":"pone.0289147.ref022","unstructured":"2019\/20+ Yearbook: Centre for Effective Practice; 2020 [cited 1 November 2022]. Available from: https:\/\/cep.health\/about-us."},{"key":"pone.0289147.ref023","first-page":"2023","article-title":"Academic detailing to improve appropriate opioid prescribing: A mixed-methods process evaluation.","volume":"20","author":"N Kithulagoda","journal-title":"CMAJ Open. Accepted April"},{"issue":"1","key":"pone.0289147.ref024","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/fampra\/cmi105","article-title":"Effects of educational outreach visits on prescribing of benzodiazepines and antipsychotic drugs to elderly patients in primary health care in southern Sweden","volume":"23","author":"P Midl\u00f6v","year":"2005","journal-title":"Family Practice"},{"issue":"2","key":"pone.0289147.ref025","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1753-6405.1995.tb00364.x","article-title":"A controlled trial of educational visiting to improve benzodiazepine prescribing in general practice.","volume":"19","author":"S de Burgh","year":"1995","journal-title":"Aust J Public Health"},{"issue":"11","key":"pone.0289147.ref026","first-page":"1104","article-title":"Benzodiazepine prescribing by GP registrars. A trial of educational outreach","volume":"29","author":"NA Zwar","year":"2000","journal-title":"Aust Fam Physician"},{"key":"pone.0289147.ref027","doi-asserted-by":"crossref","first-page":"f4403","DOI":"10.1136\/bmj.f4403","article-title":"Improving antibiotic prescribing in acute respiratory tract infections: cluster randomised trial from Norwegian general practice (prescription peer academic detailing (Rx-PAD) study).","volume":"347","author":"S Gjelstad","year":"2013","journal-title":"BMJ: British Medical Journal"},{"issue":"1","key":"pone.0289147.ref028","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1532-5415.1998.tb01017.x","article-title":"The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes.","volume":"46","author":"I Schmidt","year":"1998","journal-title":"J Am Geriatr Soc"},{"key":"pone.0289147.ref029","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/1472-6963-10-321","article-title":"Improving the use of benzodiazepines\u2014is it possible? A non-systematic review of interventions tried in the last 20 years.","volume":"10","author":"AJ Smith","year":"2010","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"pone.0289147.ref030","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00005650-199807000-00008","article-title":"A randomized controlled trial of a drug use review intervention for sedative hypnotic medications.","volume":"36","author":"DH Smith","year":"1998","journal-title":"Med Care"},{"issue":"6","key":"pone.0289147.ref031","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/BF00196105","article-title":"The effect of industry-independent drug information on the prescribing of benzodiazepines in general practice","volume":"46","author":"D Berings","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"pone.0289147.ref032","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/02813439008994941","article-title":"Intervention against long-term use of hypnotics\/sedatives in general practice.","volume":"8","author":"M. Holm","year":"1990","journal-title":"Scand J Prim Health Care"},{"issue":"1","key":"pone.0289147.ref033","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12875-021-01415-x","article-title":"Reducing prescribing of benzodiazepines in older adults: a comparison of four physician-focused interventions by a medical regulatory authority.","volume":"22","author":"N Ashworth","year":"2021","journal-title":"BMC Family Practice"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0289147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T17:36:18Z","timestamp":1690479378000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0289147"}},"subtitle":[],"editor":[{"given":"Kathleen","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0289147","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,27]]}}}